Company news

OptimizeRx Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

July 14, 2024

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

June 19, 2024

OptimizeRx Reports First Quarter 2024 Financial Results

May 13, 2024

OptimizeRx to Participate in Upcoming Investor Conferences

May 5, 2024

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4: 30 p.m. ET

April 25, 2024

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

April 17, 2024

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

April 15, 2024

OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row

April 10, 2024

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8: 30 a.m. ET

March 24, 2024

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

March 10, 2024

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort

March 3, 2024

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

January 24, 2024

OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update

January 8, 2024

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

December 17, 2023

OptimizeRx Reports Third Quarter 2023 Financial Results

November 5, 2023

OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8: 30 a.m. ET

October 24, 2023

OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers

October 11, 2023

OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform

September 25, 2023

OptimizeRx Expands AI Powered Omnichannel Platform

August 23, 2023

OptimizeRx Reports Second Quarter 2023 Financial Results

August 13, 2023

OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4: 30 p.m. ET

July 30, 2023

OptimizeRx’s CEO Provides 2023 Midyear Strategic Update

May 23, 2023

OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100

May 17, 2023

OptimizeRx Reports First Quarter 2023 Financial Results

May 9, 2023

Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance

May 1, 2023

OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4: 30 p.m. ET

April 25, 2023

OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report

April 3, 2023

Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year

March 28, 2023

OptimizeRx Authorizes $15 Million Share Repurchase Program

March 13, 2023

OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients

March 8, 2023

OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results

March 7, 2023

OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4: 30 p.m. ET

February 22, 2023

OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars

February 8, 2023

OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference

January 3, 2023

OptimizeRx Reports Third Quarter 2022 Financial Results

November 7, 2022

OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event

October 19, 2022

OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4: 30 p.m. ET

October 18, 2022

OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution

October 10, 2022

OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands

September 19, 2022

OptimizeRx to Participate in Upcoming September Conferences

September 6, 2022

OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program

August 22, 2022

OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

August 8, 2022

OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership

July 25, 2022

OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4: 30 p.m. ET

July 20, 2022

OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership

June 22, 2022

OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution

June 6, 2022

OptimizeRx to Participate in Upcoming June Conferences

May 23, 2022

OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100

May 16, 2022

OptimizeRx Authorizes $20 Million Share Repurchase Program

May 16, 2022

OptimizeRx to Participate in Upcoming May Conferences

May 9, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.